background
sar
coronaviru
identifi
caus
sever
acut
respiratori
syndrom
sar
test
allow
confirm
exclus
sar
within
first
day
infect
gene
chip
use
tool
studi
microbi
infect
mainli
capabl
perform
multitarget
analysi
singl
test
object
investig
possibl
earli
detect
sar
viru
clinic
sampl
use
gene
chipbas
method
studi
design
purifi
rna
sarscov
obtain
routin
collect
peripher
blood
sputum
sampl
patient
identifi
probabl
sar
patient
follow
interim
us
case
definit
four
segment
sarscov
amplifi
use
revers
transcriptionnest
pcr
product
examin
use
gene
chip
sarscov
detect
result
blindtest
peripher
blood
sputum
specimen
lead
posit
detect
sarscov
patient
sarscov
found
peripher
blood
sputum
specimen
three
patient
two
patient
day
postonset
symptom
subsequ
confirm
sar
posit
result
indic
gene
chipbas
molecular
test
specif
sarscov
allow
earli
detect
patient
sar
detect
rate
higher
singl
pcr
test
sputum
sampl
avail
sever
acut
respiratori
syndrom
sar
newli
emerg
diseas
associ
pneumonia
infect
patient
world
health
organ
novemb
june
sar
viru
infect
peopl
caus
death
worldwid
wwwwhoint
access
juli
genom
sarscov
sequenc
marra
et
al
ruan
et
al
earlier
case
sar
viru
detect
less
chanc
patient
spread
diseas
other
variou
serolog
molecular
test
develop
detect
viru
confirm
infect
method
includ
enzymelink
immunosorb
assay
elisa
ksiazek
et
al
indirect
immunofluoresc
assay
ifa
revers
transcript
rt
follow
realtim
pcr
use
either
taqman
techniqu
intercal
fluoresc
dye
approach
drosten
et
al
peiri
et
al
yet
test
allow
confirm
exclus
sar
within
first
day
infect
serolog
method
close
window
period
use
earli
detect
realtim
pcr
detect
one
target
sequenc
time
mean
fals
neg
result
possibl
genom
sarscov
posit
ssrna
mean
mrna
sequenc
sarscov
genom
sequenc
henc
copi
number
sarscov
calcul
directli
quantit
result
realtim
pcr
gene
chip
provid
use
tool
studi
microbi
infect
cheng
kricka
wang
et
al
tao
et
al
mainli
capabl
perform
multitarget
analysi
one
test
recent
report
use
gene
chip
detect
pathogen
bacteria
virus
clinic
relev
sampl
chang
gene
express
among
drugtreat
untreat
microb
cheng
et
al
tao
et
al
zhang
et
al
paper
report
method
earli
detect
sar
viru
clinic
specimen
sar
patient
method
combin
conveni
sampl
prepar
method
nucleic
acid
amplif
use
modifi
nest
pcr
gene
chip
array
probe
select
cover
repres
region
sarscov
genom
peripher
blood
sputum
sampl
collect
patient
suffer
sar
tsinghua
univers
jiuxianqiao
hospit
patient
identifi
probabl
sar
patient
follow
interim
us
case
definit
probabl
sar
case
definit
base
clinic
criteria
epidemiolog
linkag
sar
case
radiograph
evid
neg
control
includ
peripher
blood
sampl
sputum
sampl
collect
univers
student
tsinghua
determin
free
infect
base
radiolog
temperatur
measur
follow
experi
one
neg
blood
control
sampl
sputum
sampl
includ
clinic
blood
sampl
sputum
sampl
sampl
pretreat
extract
stage
control
monitor
occurr
contamin
may
appear
sampl
treatment
process
addit
one
blank
control
use
water
templat
includ
rtpcr
reaction
clinic
sampl
control
pcr
procedur
sequenc
data
sarscov
obtain
curat
databas
genbank
uniqu
conserv
region
sarscov
select
align
releas
sarscov
sequenc
latest
nonredund
nucleic
acid
sequenc
databas
ncbi
ftp
ftpncbinihgov
enabl
earli
detect
sarscov
multipl
region
open
read
frame
orf
replicas
spike
glycoprotein
nucleocapsid
protein
rota
et
al
select
target
hybrid
minim
crosshybrid
oligonucleotid
design
follow
rule
http
wwwwestburgnldownloadarrayposterpdf
increas
immobil
effici
probe
thymidin
ad
end
probe
initi
screen
test
set
four
oligonucleotid
sangon
shanghai
china
chose
probe
identifi
sarscov
see
fig
addit
set
probe
control
purpos
also
includ
qc
probe
use
confirm
effici
attach
chemistri
surfac
substrat
test
probe
alway
gener
strong
consist
fluoresc
signal
ic
probe
design
guarante
sampl
process
procedur
entir
nest
rtpcr
process
oper
expect
ec
probe
use
monitor
effici
hybrid
process
also
refer
quantifi
amplicon
hybrid
signal
bc
dmso
spot
substrat
ensur
signal
detect
spot
indic
guarante
carryov
previous
spot
sampl
probe
suspend
dimethyl
sulfoxid
dmso
concentr
print
glass
slide
modifi
amino
group
aminoslid
tm
capitalbio
corp
beij
china
array
print
accord
spot
pattern
fig
b
duplic
slide
sequenc
inform
probe
list
tabl
concern
current
gene
chip
design
fifteen
possibl
combin
occurr
sarscov
posit
signal
long
one
fifteen
combin
shown
fig
c
detect
presenc
sarscov
ensur
bcdmso
spot
blank
control
qchexlabel
oligonucleotid
use
qualiti
control
surfac
chemistri
icintern
control
probe
nest
rtpcr
hybrid
ecextern
control
probe
hybridizationbas
quantit
ncneg
control
probe
select
sarscov
orf
nthe
probe
select
sarscov
orf
nucleocapsid
protein
sthe
probe
select
sarscov
orf
spike
glycoprotein
fresh
edtaanticoagul
peripher
blood
ml
spun
g
min
upperlay
plasma
replac
volum
physiolog
salin
solut
equival
amount
plasma
resuspend
blood
cell
ml
test
tube
ad
ml
ficol
solut
follow
resuspend
blood
cell
ficol
gradient
centrifug
g
min
subsequ
lymphocyt
interfac
harvest
ml
eppendorf
tube
spun
g
min
supernat
remov
l
buffer
avl
qiaamp
viral
rna
mini
kit
qiagen
chatsworth
ca
ad
lyse
pellet
lymphocyt
sputum
specimen
collect
ml
test
tube
kept
c
process
sputum
sampl
shaken
room
temperatur
equal
volum
acetylcystein
sigma
st
loui
mo
nacl
tabl
sequenc
inform
probe
print
gene
chip
name
probe
sequenc
qc
tttttttttttgtcttccaccaggagtcagcagagtgcttgg
tgccataachex
ic
ttttttttttcgtcaaggctgagaacgggaagcttgtcatcaatggaaatcccatcaccatcttccaggagcgagatccc
ec
ttttttttttaaagttaaagcagaccgaagtggattgcgagtatttgaaaagatgtgttgagaaattaacggaagagaa
nc
ttttttttttagtggtggacctgacctgccgtctagaaaaacctgccaaatatgatgacatcaagaaggtggtgaagcag
ttttttttttctacgtagtgaagctttcgagtactaccatactcttgatgagagttttcttggtaggtacatgtctgctt
tttttttttttcatagctaacatctttactcctcttgtgcaacctgtgggtgctttagatgtgtctgcttcagtagtggc
ttttttttttgaggtggtgaaactgccctcgcgctattgctgctagacagattgaaccagcttgagagcaaagtttctgg
ttttttttttcacctggaacaaatgcttcatctgaagttgctgttctatatcaagatgttaactgcactgatgtttctac
revolutionmin
min
subsequ
l
buffer
avl
ad
ml
eppendorf
tube
follow
addit
l
homogen
isol
total
rna
l
elut
volum
accomplish
qiaamp
viral
rna
mini
kit
improv
detect
limit
modifi
nest
rtpcr
method
appli
amplifi
four
segment
three
orf
genom
sar
coronaviru
four
set
outer
primer
inner
primer
select
tabl
four
outer
primer
pair
design
set
optim
c
pcr
product
size
bp
rozen
skaletski
two
univers
primer
allow
bind
end
pcr
product
amplifi
inner
primer
effici
label
pcr
product
primer
align
use
blastn
latest
nonredund
nucleic
acid
sequenc
databas
avoid
misprim
align
releas
sarscov
sequenc
ensur
effici
prime
primer
amplifi
human
dehydrogenas
gapdh
genbank
access
nm
gene
human
rna
intern
control
entir
process
name
sampl
prepar
pcr
amplif
chip
hybrid
primer
amplifi
gene
genbank
access
arbidopsi
thaliana
control
hybrid
univers
primer
incorpor
fluoresc
dye
list
tabl
abovement
primer
synthes
sangon
reaction
condit
rtpcr
follow
first
round
reaction
nest
rtpcr
one
step
rtpcr
second
round
reaction
pcr
use
product
first
round
templat
one
step
rtpcr
kit
takara
dalian
china
use
first
round
reaction
condit
follow
total
volum
reaction
l
includ
l
total
rna
includ
human
total
rna
viral
rna
either
patient
sampl
normal
person
sampl
l
diethyl
pyrocarbon
treat
deioniz
water
blank
control
one
step
rna
pcr
buffer
mmoll
mgcl
ul
rnase
inhibitor
ul
amv
rtase
xl
ul
amvoptim
taq
moll
outer
primer
ic
primer
mmoll
deoxynucleosid
triphosph
reaction
perform
thermal
cycler
mj
research
inc
miami
fl
thermal
condit
follow
one
cycl
c
min
one
cycl
c
min
cycl
c
c
c
min
one
cycl
c
min
master
mixtur
twtime
beij
china
use
second
round
reaction
condit
follow
total
volum
reaction
l
includ
l
rtpcr
product
first
round
templat
ng
plasmid
templat
ec
l
deioniz
water
blank
control
master
mixtur
mmoll
dutp
sangon
ul
uracildna
glycosylas
invitrogen
carlsbad
ca
ngml
rnase
sigma
moll
inner
primer
ec
primer
moll
univers
primer
reaction
perform
thermal
cycler
thermal
condit
follow
one
cycl
c
min
one
cycl
c
min
one
cycl
c
min
cycl
c
c
c
min
one
cycl
c
min
pcr
product
load
onto
agaros
gel
along
l
dna
molecular
marker
takara
dalian
china
run
vcm
min
photograph
use
uvp
system
ultraviolet
product
cambridg
uk
prepar
hybrid
sampl
equal
volum
amplicon
l
remov
nest
rtpcr
reaction
posit
control
reaction
respect
mix
hybrid
sampl
ad
l
hybrid
solut
ssc
denhart
solut
sd
mixtur
briefli
centrifug
denatur
doublestrand
dna
hybrid
sampl
heat
c
min
follow
snap
chill
ice
min
slide
four
reaction
well
place
hybrid
chamber
preload
l
doubledistil
water
plastic
cover
mold
sampleload
hole
smartcov
tm
capitalbio
beij
china
place
top
slide
denatur
dna
sampl
appli
individu
reaction
well
glass
slide
load
hole
plastic
cover
final
seal
cartridg
place
c
water
bath
h
hybrid
complet
slide
remov
cartridg
cover
slip
remov
slide
wash
sequenti
prewarm
c
wash
solut
ssc
sd
min
follow
wash
solut
b
ssc
min
afterward
slide
rins
doubledistil
water
three
time
dri
centrifug
g
min
slide
scan
use
genepix
axon
instrument
union
citi
ca
scan
condit
follow
wavelength
nm
laser
power
pixel
size
pmt
voltag
bright
contrast
minim
effect
nonspecif
hybrid
fals
posit
threshold
ratio
signaltonois
implement
base
statist
analysi
hybrid
data
obtain
neg
control
sampl
four
differ
sarscov
specif
probe
immobil
gene
chip
one
follow
signal
pattern
detect
fig
c
signifi
partial
sequenc
sarscov
present
sampl
consid
posit
sarscov
fig
show
dna
electrophoresi
result
hybrid
imag
differ
control
includ
blank
control
use
doubl
distil
water
templat
neg
control
use
blood
healthi
control
sputum
sampl
posit
control
use
vero
cell
inocul
sarscov
blank
control
neg
control
test
neg
result
wherea
posit
control
produc
expect
posit
hybrid
result
fig
ad
show
dna
electrophoresi
result
genechip
hybrid
imag
patient
blood
patient
sputum
specimen
respect
blood
sampl
taken
day
postonset
symptom
sputum
sampl
taken
day
postonset
symptom
result
show
sputum
specimen
posit
presenc
sarscov
wherea
blood
sampl
neg
signal
fig
eh
show
electrophoret
result
hybrid
imag
blood
sputum
specimen
respect
second
patient
patient
blood
sampl
taken
day
postonset
symptom
sputum
sampl
taken
day
postonset
symptom
clear
sputum
specimen
posit
presenc
sarscov
signal
detect
blood
sampl
fig
il
show
electrophoret
result
hybrid
imag
blood
sputum
specimen
respect
third
patient
patient
sampl
taken
day
postonset
symptom
result
indic
blood
sputum
specimen
posit
presenc
sarscov
fig
mr
show
electrophoret
result
hybrid
imag
blood
sputum
specimen
respect
fourth
patient
patient
blood
sampl
taken
day
fig
n
day
fig
p
postonset
symptom
sputum
sampl
taken
day
fig
q
r
postonset
symptom
result
indic
blood
sputum
specimen
posit
presenc
sarscov
compar
studi
posit
detect
rate
gene
chip
singl
probe
fourcombin
probe
blood
sputum
blood
sputum
summar
tabl
patient
run
nest
rtpcr
may
may
produc
amplicon
depend
type
specimen
time
interv
sampl
howev
four
amplif
reaction
blood
sputum
combin
posit
detect
rate
chip
maxim
increas
blood
sputum
blood
sputum
result
combin
singl
probe
use
chip
highest
detect
rate
rate
approxim
lower
rate
four
probe
use
blood
sputum
earli
detect
sarscov
present
sampl
collect
sar
patient
repres
rare
event
detect
requir
effici
isol
target
viral
rna
highli
effici
amplif
specif
detect
isol
rna
effici
clinic
sampl
prepar
ensur
applic
qiaamp
viral
rna
mini
kit
amplif
effici
target
rna
amplif
guarante
nest
pcr
high
specif
detect
provid
chip
hybrid
furthermor
fals
neg
rate
greatli
reduc
combin
use
four
probe
tabl
quadrupl
secur
strategi
quit
differ
exist
method
serolog
method
realtim
pcr
one
target
detect
one
test
use
ex
ist
method
miss
one
miss
higher
risk
fals
neg
inevit
encount
sar
crisi
fals
neg
diagnost
could
disastr
public
found
combin
four
individu
nest
rtpcr
reaction
chip
hybrid
produc
maxim
sensit
gene
chipbas
earli
detect
sarscov
nest
rtpcr
amplif
system
adopt
competit
amplif
among
four
set
primer
sarscov
rna
exist
amount
templat
limit
found
orf
n
closest
proxim
region
sarscov
genom
easili
amplifi
templat
bp
posit
sputum
specimen
blood
sampl
next
easili
amplifi
orf
bp
posit
sputum
specimen
blood
sampl
may
explain
previou
report
nidoviru
structur
protein
encod
proxim
region
genom
individu
express
nest
set
subgenom
mrna
gener
uniqu
discontinu
transcript
mechan
ziebuhr
et
al
least
five
subgenom
mrna
detect
northern
hybrid
rna
sarscovinfect
cell
use
probe
deriv
untransl
region
calcul
size
five
predomin
band
correspond
size
five
predict
subgenom
mrna
sarscov
rota
et
al
howev
quantiti
templat
increas
certain
level
one
even
two
remain
two
product
repres
orf
also
amplifi
bp
posit
sputum
specimen
blood
sampl
bp
posit
sputum
specimen
blood
sampl
addit
extrem
precaut
taken
prevent
cross
contamin
experi
includ
use
dutp
uracildna
glycosylas
remot
physic
isol
laboratori
sampl
prepar
pcr
prepar
electrophoret
examin
hybrid
amplicon
result
fig
af
show
nonspecif
amplif
occur
blank
control
nonspecif
hybrid
signal
probe
fig
b
appear
probe
orf
n
gener
weak
posit
signal
yet
fact
hybrid
result
categor
neg
signaltonois
ratio
much
less
threshold
valu
blood
sputum
sampl
healthi
control
produc
neg
hybrid
signal
four
sarscov
specif
probe
yet
result
fig
g
h
demonstr
four
sarscov
specif
pcr
product
amplifi
detect
expect
suffici
amount
sarscov
rna
use
templat
result
shown
fig
ah
clearli
seen
patient
day
postonset
symptom
rna
sarscov
detect
blood
sampl
wherea
abund
copi
rna
sarscov
detect
two
patient
sputum
specimen
result
impli
sputum
good
specimen
earli
detect
presenc
sarscov
result
fig
j
n
show
earliest
detect
rna
sarscov
blood
specimen
day
postonset
symptom
fig
mp
see
presenc
sarscov
blood
increas
dramat
day
onset
symptom
compar
result
obtain
day
onset
symptom
among
patient
test
four
earli
patient
posit
identifi
presenc
sarscov
specimen
patient
also
posit
presenc
sarscov
one
patient
day
postonset
symptom
still
test
posit
presenc
sarscov
blood
sputum
sampl
remain
three
patient
neg
sarscov
elisa
test
conduct
blood
sampl
collect
three
patient
patient
day
day
postonset
symptom
found
posit
incomprehens
gene
chip
test
result
match
elisa
result
former
patient
day
postonset
symptom
howev
gene
chip
elisa
result
could
interpret
easili
patient
day
postonset
symptom
viral
load
may
reduc
zero
day
medic
treatment
accord
time
cours
studi
viral
load
data
shown
patient
day
postonset
symptom
test
neg
elisa
test
gene
chip
could
well
misidentifi
nonsar
patient
shown
nucleic
acid
analysi
highli
effect
earli
detect
sarscov
one
major
advantag
adopt
gene
chip
base
strategi
multitarget
analysi
possibl
singl
test
mean
higher
throughput
sensit
higher
specif
singl
probe
use
gene
chip
highest
detect
rate
approxim
lower
rate
four
probe
use
one
target
chosen
case
realtim
pcr
higher
risk
fals
neg
inevit
although
agaros
gel
electrophoresi
could
use
examin
rtpcr
amplicon
result
inconclus
clinic
purpos
sequenc
inform
amplicon
avail
henc
fals
posit
result
may
produc
improv
desir
current
gene
chip
approach
sar
diagnosi
foursepar
nest
rtpcr
reaction
slow
laborintens
expens
result
shown
howev
primari
studi
design
meet
requir
impos
sarscrisi
modifi
pcr
univers
primer
genespecif
primer
label
design
initi
multiplex
amplif
avoid
preferenti
amplif
ordinari
multiplex
pcr
base
success
current
studi
effort
underway
develop
multiplex
nest
rtpcr
allow
separ
nest
rtpcr
reaction
combin
singl
reaction
tube
method
develop
oper
conveni
faster
gene
chip
base
method
could
transfer
research
servic
set
appli
identif
microorgan
summari
earli
detect
sarscov
made
possibl
combin
four
nest
rtpcr
reaction
gene
chip
assay
sputum
blood
ideal
sampl
detect
sarscov
earli
diagnosi
sar
furthermor
gene
chipbas
earli
detect
strategi
appli
newli
emerg
infecti
pathogen
